Zimmer Biomet Holdings, Inc. (SWX:ZBH)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
71.81
0.00 (0.00%)
At close: Sep 29, 2025
Market Cap15.51B
Revenue (ttm)6.23B
Net Income (ttm)654.91M
Shares Outn/a
EPS (ttm)3.27
PE Ratio23.69
Forward PE11.75
Dividend0.82 (1.14%)
Ex-Dividend DateJun 26, 2025
Volumen/a
Average Volumen/a
Openn/a
Previous Close71.81
Day's Rangen/a
52-Week Range71.81 - 119.00
Beta1.01
RSI0.00
Earnings DateNov 7, 2025

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear... [Read more]

Sector Healthcare
Founded 1927
Employees 17,000
Stock Exchange SIX Swiss Exchange
Ticker Symbol ZBH
Full Company Profile

Financial Performance

In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.

Financial numbers in USD Financial Statements

News

Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System

iTaperloc® Complete and iG7™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint Infec...

5 days ago - PRNewsWire

Stifel Maintains Buy Rating on Zimmer Biomet Holdings (ZBH), Raises Price Target | ZBH Stock News

Stifel Maintains Buy Rating on Zimmer Biomet Holdings (ZBH), Raises Price Target | ZBH Stock News

11 days ago - GuruFocus

Zimmer Biomet Holdings (ZBH) Receives 'Buy' Rating from Rothschild & Co | ZBH Stock News

Zimmer Biomet Holdings (ZBH) Receives 'Buy' Rating from Rothschild & Co | ZBH Stock News

12 days ago - GuruFocus

How To YieldBoost Zimmer Biomet Holdings To 7.7% Using Options

Shareholders of Zimmer Biomet Holdings Inc (Symbol: ZBH) looking to boost their income beyond the stock's 1% annualized dividend yield can sell the January 2027 covered call at the $110 strike and col...

14 days ago - Nasdaq

Insider Decision: Sang Yi Offloads $124K Worth Of Zimmer Biomet Holdings Stock

Sang Yi , Group President at Zimmer Biomet Holdings (NYSE: ZBH), disclosed an insider sell on September 15, according to a recent SEC filing. What Happened: Yi's decision to sell 1,200 shares of Zimm...

14 days ago - Benzinga

Insider Sell: Sang Yi Sells 1,200 Shares of Zimmer Biomet Holdings Inc (ZBH)

Insider Sell: Sang Yi Sells 1,200 Shares of Zimmer Biomet Holdings Inc (ZBH)

15 days ago - GuruFocus

Notable Two Hundred Day Moving Average Cross - ZBH

In trading on Monday, shares of Zimmer Biomet Holdings Inc (Symbol: ZBH) crossed below their 200 day moving average of $101.89, changing hands as low as $100.77 per share. Zimmer Biomet Holdings Inc s...

15 days ago - Nasdaq

Zimmer Biomet Holdings (ZBH) Issues New Swiss Franc-Denominated Bonds

Zimmer Biomet Holdings (ZBH) Issues New Swiss Franc-Denominated Bonds

25 days ago - GuruFocus

Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle ...

Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference | ZBH Stock News

26 days ago - GuruFocus

Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference

WARSAW, Ind., Sept. 4, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its participation in the American Orthopedic Foot and ...

26 days ago - PRNewsWire

Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care

Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants Dr. Anand M.

4 weeks ago - PRNewsWire

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025

WARSAW, Ind. , Aug. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment ...

4 weeks ago - PRNewsWire

Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference

WARSAW, Ind. , Aug. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Annual Morgan ...

5 weeks ago - PRNewsWire

Looking Into Zimmer Biomet Holdings's Recent Short Interest

Zimmer Biomet Holdings's (NYSE: ZBH) short percent of float has fallen 19.29% since its last report. The company recently reported that it has 5.93 million shares sold short , which is 3.43% of all r...

6 weeks ago - Benzinga

4 Stocks to Buy From a Top-Performing Fund Manager

Bill Nygren's Oakmark Fund recently took new positions in these undervalued stocks.

7 weeks ago - Morningstar

Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99 . The orthopedic implant maker repor...

7 weeks ago - Benzinga

Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook

Zimmer Biomet Holdings, Inc. ZBH reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99.

7 weeks ago - Benzinga

Zimmer Biomet (ZBH) Q2 Revenue Jumps 7%

7 weeks ago - The Motley Fool

Zimmer Biomet raises annual profit forecast on strong demand for medical devices

Zimmer Biomet Holdings raised its full-year adjusted profit forecast and beat second-quarter earnings expectations on Thursday, bolstered by accelerating demand for its hip and knee implants.

7 weeks ago - Reuters

Zimmer Biomet Q2 2025 Earnings Preview

7 weeks ago - Seeking Alpha

Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What's Fueling the Surge? | MarketsandMarkets™.

Delray Beach, FL, July 30, 2025 (GLOBE NEWSWIRE) -- The global Advanced Wound Care Market , valued at US$12.48 billion in 2024 stood at US$13.37 billion in 2025 and is projected to advance at a resili...

2 months ago - Benzinga

What Does the Market Think About Zimmer Biomet Holdings?

Zimmer Biomet Holdings's (NYSE: ZBH) short percent of float has fallen 13.09% since its last report. The company recently reported that it has 7.34 million shares sold short , which is 4.25% of all r...

2 months ago - Benzinga